As shown above with peptides, and in Tables 2 and 3 with non-peptide compounds, many different MCHR1 antagonists have demonstrated modest to robust efficacy in a variety of rodent obesity models, suggesting that MCHR1 antagonists may have potential for treating human obesity. The gene discussed is MCHR1; the disease is obesity disorder.